New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 20 mg/ml - solution for injection - 20 mg/ml - active: hyoscine butylbromide 20 mg/ml excipient: sodium chloride water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - clomipramine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: purified talc; maize starch; lactose monohydrate; sodium starch glycollate; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 400 - for the treatment o f major depression; obsessive-compulsive disorders and phobias in adults; and cataplexy associated with narcolepsy.

Egypt - English - EDA (Egyptian Drug Authority)

boehringer ingelheim germany - coated tablet

Malta - English - Medicines Authority

alphafarma limited - hyoscine butylbromide - coated tablet - hyoscine butylbromide 10 milligram(s) - drugs for functional gastrointestinal disorders

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

opella healthcare belgium sa-nv - hyoscine butylbromide 20 mg - film-coated tablet - 20 mg - butylhyoscine bromide 20 mg - butylscopolamine

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine - unii:2z3e1of81v) - butylscopolamine bromide 20 mg in 1 ml - buscopan is indicated for the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions in horses. buscopan should not be used in impaction colics associated with ileus, or in horses with glaucoma.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - hyoscine butylbromide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -